These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26806138)

  • 1. Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance-a retrospective population based study from Finland and Sweden.
    Jääskeläinen IH; Hagberg L; From J; Schyman T; Lehtola L; Järvinen A
    Clin Microbiol Infect; 2016 Apr; 22(4):383.e1-383.e10. PubMed ID: 26806138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential benefit from infectious disease specialist and stationary ward in rational antibiotic therapy of complicated skin and skin structure infections.
    Jääskeläinen IH; Hagberg L; Schyman T; Järvinen A
    Infect Dis (Lond); 2018 Feb; 50(2):107-116. PubMed ID: 28789580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.
    Garau J; Ostermann H; Medina J; Avila M; McBride K; Blasi F;
    Clin Microbiol Infect; 2013 Sep; 19(9):E377-85. PubMed ID: 23663184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin.
    Owens RC; Lamp KC; Friedrich LV; Russo R
    Am J Med; 2007 Oct; 120(10 Suppl 1):S6-12. PubMed ID: 17904950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.
    Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Kim M
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):273-9. PubMed ID: 24661685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors.
    Zilberberg MD; Shorr AF; Micek ST; Hoban AP; Pham V; Doherty JA; Ramsey AM; Kollef MH
    Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1203-10. PubMed ID: 19848604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.
    Ostermann H; Blasi F; Medina J; Pascual E; McBride K; Garau J;
    J Med Econ; 2014 Oct; 17(10):719-29. PubMed ID: 24983206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
    Kern WV
    Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.
    Montravers P; Bassetti M; Dupont H; Eckmann C; Heizmann WR; Guirao X; García MS; Capparella MR; Simoneau D; Bodmann KF
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii15-24. PubMed ID: 23772042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.
    Corey GR; Good S; Jiang H; Moeck G; Wikler M; Green S; Manos P; Keech R; Singh R; Heller B; Bubnova N; O'Riordan W;
    Clin Infect Dis; 2015 Jan; 60(2):254-62. PubMed ID: 25294250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance to antibiotic guidelines leads to more appropriate use of antibiotics in skin and soft tissue infections in injecting drug users.
    Nymoen Aasbrenn M; Skeie I; Berild D
    Infect Dis (Lond); 2019 Aug; 51(8):570-577. PubMed ID: 31144548
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013.
    Li X; Chen Y; Gao W; Ouyang W; Wei J; Wen Z
    PLoS One; 2016; 11(2):e0149960. PubMed ID: 26918456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.
    Teppler H; McCarroll K; Gesser RM; Woods GL
    Surg Infect (Larchmt); 2002; 3(4):337-49. PubMed ID: 12697080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with time to clinical stability in complicated skin and skin structure infections.
    Jääskeläinen IH; Hagberg L; Forsblom E; Järvinen A
    Clin Microbiol Infect; 2017 Sep; 23(9):674.e1-674.e5. PubMed ID: 28274771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.
    Eckmann C; Heizmann W; Bodmann KF; von Eiff C; Petrik C; Loeschmann PA
    Surg Infect (Larchmt); 2015 Oct; 16(5):618-25. PubMed ID: 26115414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.
    Pfaller MA; Rhomberg PR; Sader HS; Mendes RE; Jones RN
    J Chemother; 2010 Oct; 22(5):304-11. PubMed ID: 21123152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin for Complicated Skin Infections: A Randomized Trial.
    Bradley J; Glasser C; Patino H; Arnold SR; Arrieta A; Congeni B; Daum RS; Kojaoghlanian T; Yoon M; Anastasiou D; Wolf DJ; Bokesch P
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28202770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characteristics of Gram-positive bacteria isolated from skin lesions observed in ambulatory patients and the assessment of their susceptibility to antimicrobial drugs].
    Sikora A; Kozioł-Montewka M; Bogut A
    Przegl Lek; 2011; 68(4):196-201. PubMed ID: 21853673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for mixed complicated skin and skin structure infections to help tailor appropriate empiric therapy.
    Zilberberg M; Micek ST; Kollef MH; Shelbaya A; Shorr AF
    Surg Infect (Larchmt); 2012 Dec; 13(6):377-82. PubMed ID: 23216526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.